Vapreotide
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Trade names | Sanvar |
ATC code | |
Pharmacokinetic data | |
Biological half-life | 30 minutes |
Identifiers | |
|
|
Synonyms | H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2 Octastatin |
CAS Number | |
PubChem CID | |
PubChem SID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C57H70N12O9S2 |
Molar mass | 1131.37 g/mol |
3D model (Jmol) | |
Density | 1.4 g/cm3 |
Boiling point | 1,540.9 °C (2,805.6 °F) |
|
|
|
Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea.[1]
It is an 8 residue peptide with sequence H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2.
References[edit]
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |